rna
interfer
rnai
promot
silenc
gene
express
posttranscript
deliveri
exogen
doublestrand
small
interf
rna
dssirna
typic
consist
base
pair
target
rnainduc
silenc
complex
risc
locat
cell
cytoplasm
consid
promis
therapeut
approach
treatment
broad
rang
rnaibas
therapi
also
shown
great
potenti
treatment
pulmonari
disord
includ
lung
cystic
chronic
obstruct
pulmonari
diseas
copd
respiratori
syncyti
viru
rsv
sever
acut
respiratori
syndrom
sar
viral
howev
progress
sirnabas
technolog
target
lung
ailment
hinder
lack
adequ
carrier
capabl
overcom
extra
intracellular
barrier
present
lung
tissu
challeng
formul
sirna
carrier
portabl
oral
inhal
oi
devic
local
deliveri
sirna
poli
amidoamin
pamam
dendrim
highli
monodispers
hyperbranch
polym
contain
easili
functionaliz
surfac
group
thu
repres
promis
structur
construct
effect
drug
carrier
gene
transfer
aminetermin
pamam
dendrim
surfac
group
primari
amin
proton
physiolog
thu
effici
bind
nucleic
acid
form
nanoscal
complex
term
may
offer
opportun
improv
target
sirna
cell
cytosol
even
though
mani
public
address
transfect
cell
use
report
discuss
gene
silenc
antisens
pamam
dendrim
cell
model
lung
alveolar
epithelium
suitabl
carrier
deliveri
sirna
cytosol
lung
cell
found
anoth
import
consider
abil
target
complex
lung
oi
promis
rout
administr
sirna
pulmonari
epithelium
sinc
provid
direct
noninvas
mean
target
pressur
metereddos
inhal
pmdi
import
devic
within
context
sirna
deliveri
lung
least
expens
wide
use
oi
devic
pmdi
portabl
long
shelf
life
reliabl
use
even
patient
compromis
lung
function
propel
howev
due
formul
challeng
report
literatur
date
sirna
system
formul
pmdi
basi
challeng
opportun
discuss
propos
work
develop
propellantbas
oi
formul
complex
effici
silenc
gene
lung
epithelium
report
prepar
character
dendriplex
evalu
vitro
gene
knockdown
effici
model
lung
alveolar
epitheli
cell
line
propos
differ
formul
strategi
dendriplex
studi
aerosol
perform
relev
studi
stem
fact
first
work
report
formul
inhal
sirna
aerosol
properti
suitabl
deep
lung
deposit
pmdi
least
expens
wide
use
portabl
inhal
avail
market
studi
relev
also
first
time
show
dendriplex
effici
target
lung
alveolar
epitheli
cell
silenc
gene
even
sirna
expos
propel
environ
generationfour
aminetermin
poli
amidoamin
dendrim
pamam
g
surfac
group
purchas
dendritech
inc
midland
mi
usa
provid
methanol
ww
methanol
remov
help
rotari
evapor
buchi
doublestrand
sirna
sens
uuc
agg
guc
agc
uug
c
antisens
agc
uga
ccc
uga
agu
u
purchas
bioneer
inc
alameda
ca
usa
doublestrand
dicer
substrat
sirna
dssirna
target
egfp
sens
acc
cug
aag
uuc
auc
ugc
acc
ac
antisens
cgg
ugg
ugc
aga
uga
acu
uca
ggg
respect
mismatch
integr
dna
technolog
idt
leuven
belgium
use
gene
knockdown
experi
capit
letter
repres
ribonucleotid
underlin
base
depict
lower
case
letter
repres
p
dtdt
depict
addit
phosphat
thymin
overhang
respect
deioniz
water
diwat
resist
cm
obtain
nanopur
diamond
uv
ultrapur
water
system
barnstead
intern
dubuqu
ia
usa
treat
vv
diethylpyrocarbon
depc
overnight
follow
autoclav
depc
high
puriti
ethylenediaminetetraacet
acid
edta
steril
solut
ph
depc
treat
purchas
amresco
solon
oh
usa
cell
passag
lung
adenocarcinoma
cell
line
vitro
model
type
ii
alveolar
sourc
atcc
manassa
va
usa
gibco
dulbecco
modifi
eagl
medium
dmem
high
glucos
glutamax
pyruv
gibco
penicillinstreptomycin
liquid
ab
quantit
picogreen
lipofectamin
transfect
reagent
purchas
invitrogen
life
technolog
grand
island
ny
usa
fetal
bovin
serum
fb
advantag
nonheat
inactiv
purchas
atlanta
biolog
inc
norcross
ga
usa
trypsin
edta
corn
cellgro
trypsin
mm
edta
hank
balanc
salt
solut
hbss
purchas
mediatech
inc
manassa
va
usa
celltit
aqueou
nonradioact
cell
prolifer
assay
mt
reagent
powder
transfast
transfect
reagent
purchas
promega
corpor
madison
wi
usa
phenazin
methosulf
pm
purchas
mp
biomed
santa
ana
ca
usa
egfp
lentivir
particl
ifu
puromycin
gene
rsv
promot
allow
select
transduc
fluoresc
posit
cell
purchas
gentarget
inc
san
diego
ca
usa
puromycin
dihydrochlorid
mg
purchas
toku
bellingham
wa
usa
cell
cultur
flask
cellstar
costar
cell
cultur
micropl
flat
bottom
tissu
cultur
treat
polystyren
steril
purchas
corn
inc
life
scienc
tewksburi
usa
ninetysixwel
micropl
black
flat
bottom
shape
polypropylen
purchas
greiner
bio
one
monro
nc
usa
ribonucleas
rnase
u
solid
bovin
pancrea
heparin
sodium
salt
u
porcin
intestin
mucosa
dmannitol
minimum
chitosan
cs
kda
degre
deacetyl
lactid
la
tin
ii
stannou
octoat
purchas
sigmaaldrich
st
loui
mo
usa
ribolock
rnase
inhibitor
ri
u
purchas
thermo
scientif
part
thermo
fisher
scientif
waltham
usa
seakem
le
agaros
purchas
lonza
rockland
usa
ethidium
bromid
mg
purchas
ibi
scientif
peosta
ia
usa
tri
base
ultrapur
bioreag
purchas
j
baker
avantor
perform
materi
center
valley
pa
usa
glacial
acet
acid
citric
acid
anhydr
phosphat
buffer
salin
pb
solut
microscop
cover
glass
mm
mm
purchas
fisher
scientif
part
thermo
fisher
scientif
waltham
usa
trishcl
ph
trisedta
te
ph
buffer
purchas
boston
bioproduct
ashland
usa
dibas
sodium
phosphat
anhydr
purchas
emd
millipor
billerica
usa
ethyl
acet
purchas
mallinckrodt
chemic
present
macron
chemic
avantor
perform
materi
center
valley
pa
usa
propel
dymel
eap
gift
dupont
wilmington
de
usa
hpfp
dupont
vertrel
xf
purchas
tmc
industri
inc
waconia
mn
usa
deuter
dimethyl
sulfoxid
purchas
cambridg
isotop
laboratori
inc
tewksburi
usa
silicon
atom
forc
microscopi
afm
probe
forc
modul
light
tap
khz
n
purchas
budget
sensor
distribut
nanoandmor
usa
ladi
island
sc
usa
mica
sheet
purchas
ted
pella
inc
red
ca
usa
dendriplex
form
combin
equal
volum
neg
charg
sirna
rnase
free
diwat
posit
charg
pamam
mm
trishcl
ph
buffer
rnase
free
sirna
solut
ad
dropwis
solut
vortex
rpm
vwr
digit
vortex
mixer
min
dispers
kept
room
temperatur
least
min
experi
order
ensur
complet
format
concentr
vari
order
prepar
dendriplex
differ
np
molar
ratio
primari
amin
group
n
phosphat
group
p
dendriplex
dispers
minimum
five
independ
batch
n
quantit
analyz
use
picogreen
synergi
micropl
reader
biotek
vt
uncomplex
sirna
content
calcul
use
linear
calibr
curv
sirna
concentr
vs
fluoresc
unit
picogreen
ultrasensit
fluoresc
nucleic
acid
stain
use
quantifi
doublestrand
dna
dsdna
dssirna
sirna
complex
effici
ce
calcul
basi
differ
initi
amount
sirna
ad
format
dendriplex
nonentrap
free
sirna
remain
dendriplex
dispers
ie
indirect
measur
sirna
content
complex
pamam
within
dendriplex
light
scatter
ls
malvern
zetas
nano
zs
use
evalu
hydrodynam
size
diamet
zeta
potenti
dendriplex
sampl
dilut
nm
sirna
measur
perform
use
refract
index
viscos
dielectr
constant
buffer
size
diwat
dendriplex
form
rnase
free
diwat
calcul
use
smoluchowski
minimum
three
independ
batch
n
use
calcul
averag
size
scan
electron
microscopi
sem
jeoleo
kv
afm
pico
spm
le
molecular
imag
use
investig
geometr
size
morpholog
dendriplex
form
rnasefre
diwat
sem
imag
sever
drop
dispers
deposit
microscop
cover
glass
dri
overnight
sputterco
gold
ernest
fullan
vacuum
size
dendriplex
estim
sem
imag
use
imagej
confirm
size
rang
determin
ls
histogram
measur
diamet
particl
fit
gaussian
distribut
averag
standard
deviat
calcul
afm
imag
dendriplex
dispers
deposit
freshli
cleav
mica
sheet
incub
room
temperatur
allow
bind
dendriplex
onto
substrat
substrat
wash
drop
diwat
dri
gentl
air
flow
afm
imag
obtain
use
silicon
afm
probe
ac
tap
capac
form
complex
sirna
also
examin
gel
electrophoresi
known
volum
dendriplex
dispers
equival
ng
sirna
load
slot
cast
nondenatur
agaros
gel
wv
tri
base
acet
acid
edta
tae
ph
buffer
stain
ethidium
bromid
electrophoresi
perform
v
mini
gel
electrophoresi
min
migrat
visual
uv
irradi
fotoanalyst
investigatoreclips
uv
transillumin
fotodyn
inc
imag
record
use
fotoanalyst
pc
imag
softwar
three
rnase
protect
assay
perform
determin
minim
rnase
concentr
need
complet
degrad
free
sirna
describ
support
inform
si
ii
effect
np
ratio
protect
effici
rnase
degrad
also
evalu
briefli
dendriplex
differ
np
ratio
form
buffer
describ
earlier
dendriplex
dispers
equival
ng
sirna
incub
rnase
te
ph
buffer
rnase
per
sirna
h
follow
addit
ribolock
rnase
inhibitor
ri
u
incub
min
stop
degrad
dendriplex
dissoci
ad
heparin
u
per
sirna
te
ph
buffer
follow
incub
min
sampl
frozen
overnight
integr
sirna
determin
gel
electrophoresi
condit
appli
gel
retard
assay
iii
third
set
experi
consist
determin
effect
rnase
concentr
sirna
integr
fix
np
ratio
briefli
dendriplex
np
incub
increas
concentr
rnase
rnase
per
sirna
h
follow
treatment
ri
heparin
describ
earlier
appropri
control
free
sirna
dendriplex
rnase
heparin
treatment
includ
experi
heparin
decomplex
assay
describ
si
dendriplex
differ
np
ratio
form
buffer
describ
earlier
known
volum
citratephosph
buffer
ph
mimic
intracellular
endosomeslysosom
respect
ad
dendriplex
dispers
sirna
make
ml
sampl
incub
water
bath
aliquot
taken
time
point
place
black
micropl
frozen
collect
sampl
quantit
analyz
use
picogreen
synergi
micropl
reader
biotek
vt
amount
sirna
releas
time
calcul
use
linear
calibr
curv
sirna
concentr
vs
fluoresc
unit
take
account
amount
free
complex
sirna
remov
sampl
aliquot
experi
perform
triplic
n
cell
passag
origin
passag
provid
atcc
seed
micropl
cell
per
well
cultur
dmem
supplement
fb
ab
vv
h
thermo
scientif
incub
napco
cytotox
free
pamam
cell
rins
pb
buffer
medium
replac
regular
cultur
medium
contain
increas
concentr
dendrim
cell
kept
incub
h
cytotox
dendriplex
cell
rins
pb
buffer
medium
replac
dmem
contain
increas
concentr
dendriplex
np
sirna
form
buffer
describ
earlier
cell
kept
incub
h
overlaid
regular
cultur
medium
dendriplex
kept
contact
cell
incub
h
protocol
vitro
cytotox
dendriplex
design
accord
vitro
gene
knockdown
experiment
condit
therefor
slightli
differ
protocol
dendrim
alon
concentr
rang
sirna
use
cytotox
experi
report
design
way
concentr
sirna
appli
gene
knockdown
aerosol
character
fall
within
equal
import
incub
time
cytotox
experi
fall
within
usual
time
time
h
appli
gene
knockdown
cell
viabil
assess
mt
cell
prolifer
briefli
cell
rins
pb
buffer
dmem
ad
cell
follow
mtspm
solut
cell
incub
dmemmtspm
mixtur
h
mt
bioreduc
formazan
solubl
cultur
medium
dehydrogenas
enzym
found
metabol
activ
absorb
formazan
nm
measur
directli
micropl
molecular
devic
spectra
max
proport
number
live
cell
thu
cell
viabil
calcul
ratio
absorb
treat
incub
free
dendriplex
untreat
dendriplex
free
cell
experi
perform
appli
seven
independ
well
per
condit
n
order
evalu
knockdown
effici
achiev
sirnabas
dendriplex
cell
stabli
express
egfp
develop
detail
si
success
establish
egfp
cell
line
egfp
knockdown
experi
perform
test
dssirna
target
posit
sequenc
call
sirna
egfpmismatch
dssirna
scrambl
neg
sequenc
call
sirna
dendriplex
differ
np
ratio
form
pamam
sirna
sirna
describ
earlier
commerci
transfect
reagent
lipofectamin
transfast
use
posit
control
free
sirna
use
neg
control
egfp
knockdown
experi
perform
accord
lipofectamin
first
egfp
stabl
cell
seed
cell
cultur
flask
subcultur
approxim
confluenc
cell
cultur
medium
dmem
supplement
fb
puromycin
select
antibiot
chang
everi
day
egfp
stabl
cell
passag
origin
passag
provid
atcc
seed
micropl
cell
per
well
cultur
dmem
supplement
fb
vv
antibiot
h
thermo
scientif
incub
napco
cell
rins
pb
buffer
transfect
medium
dmem
contain
nm
sirna
equival
pmol
per
well
ad
transfect
proceed
h
transfect
medium
replac
cultur
medium
dmem
fb
antibiot
cell
return
incub
h
cell
resuspend
ml
pb
buffer
median
fluoresc
intens
mfi
measur
flow
cytometri
fac
hwcrc
bd
lsr
ii
analyz
microscopi
data
cell
untreat
nonegfp
egfp
stabl
cell
sirna
dendriplex
use
control
mfi
level
egfp
express
untreat
egfp
stabl
cell
taken
egfp
knockdown
effici
calcul
correl
egfp
express
untreat
stabl
egfp
cell
transfect
cell
effect
propel
biolog
activ
antiegfp
dssirna
also
investig
briefli
known
amount
sirna
dissolv
rnase
free
diwat
place
pressur
proof
glass
vial
frozen
overnight
lyophil
labconco
freez
zone
mbar
h
vial
close
pressur
valv
hip
propel
fill
vial
help
manual
syring
pump
hip
homebuilt
highpressur
filler
sirna
store
satur
pressur
propel
simul
pmdi
formul
free
sirna
two
month
propel
releas
depressur
sirna
allow
dri
room
temperatur
follow
dissolut
known
volum
rnase
free
diwat
make
sirna
concentr
nmol
per
ml
control
aliquot
lyophil
sirna
kept
freezer
instead
store
pressur
liquid
hfa
gene
knockdown
experi
describ
earlier
perform
sirna
evalu
effect
storag
compress
hfa
environ
transfect
experi
sirna
receiv
store
hfa
freezer
perform
minimum
triplic
n
first
biodegrad
watersolubl
hfaphil
csla
cooligom
synthes
accord
previou
csla
compos
short
segment
lactid
oligo
la
graft
onto
lowmw
cs
via
ringopen
detail
synthesi
character
found
si
emulsif
employ
prepar
microparticl
csla
load
dendriplex
briefli
mg
csla
dissolv
rnase
free
diwat
combin
dispers
np
mixtur
equival
sirna
emulsifi
ml
ethyl
acet
use
sonic
bath
vwr
set
w
min
make
waterinoil
wo
emuls
quickli
transfer
ml
ethyl
acet
microparticl
csla
shell
load
dendriplex
within
core
thu
form
collect
via
centrifug
rpm
min
dri
airflow
room
temperatur
dendriplex
np
form
buffer
describ
earlier
dendriplex
dispers
equival
sirna
combin
mg
mannitol
previous
dissolv
rnase
free
diwat
mixtur
spraydri
buchi
mini
spray
dryer
use
follow
paramet
atom
air
flow
aspir
pump
ratio
nozzl
cleaner
inlet
temperatur
outlet
temperatur
nitrogen
atom
ga
dri
mannitol
microparticl
load
dendriplex
white
powder
accumul
collect
vessel
end
glass
cyclon
collect
use
experi
sirna
load
effici
microparticl
assess
briefli
known
amount
particl
dissolv
te
ph
buffer
incub
room
temperatur
overnight
watersolubl
mannitol
csla
shell
could
broken
next
known
mass
heparin
equival
u
per
sirna
base
estim
sirna
load
microparticl
ad
mixtur
vortex
heparin
dissolut
system
incub
min
sirna
complex
could
releas
see
heparin
decomplex
assay
si
sampl
frozen
overnight
gel
electrophoresi
perform
condit
appli
gel
retard
assay
sirna
content
encapsul
microparticl
quantifi
densitometri
use
imagej
base
electrophoresi
imag
appropri
control
sirna
mix
heparin
posit
control
csla
mannitol
mix
heparin
sirna
neg
control
four
independ
batch
n
dendriplex
load
microparticl
use
calcul
averag
standard
deviat
load
addit
integr
sirna
dendriplex
format
follow
encapsul
csla
mannitol
microparticl
also
determin
size
diamet
microparticl
assess
ls
briefli
particl
load
np
dispers
hpfp
mg
per
ml
use
sonic
bath
measur
perform
use
refract
index
viscos
dielectr
constant
hpfp
model
propel
hfa
liquid
ambient
next
hpfp
evapor
ml
rnase
free
diwat
ad
microparticl
break
csla
shell
mannitol
releas
sirna
dendriplex
ls
measur
perform
use
refract
index
viscos
dielectr
constant
water
thu
hydrodynam
diamet
dendriplex
record
time
presenc
csla
mannitol
dissolv
aqueou
medium
sem
use
investig
geometr
size
morpholog
microparticl
dispers
hpfp
use
sonic
bath
sever
drop
dispers
deposit
microscop
cover
glass
hpfp
quickli
evapor
air
flow
glass
sputterco
gold
ernest
fullan
vacuum
follow
sem
imag
known
mass
microparticl
csla
mannitol
encapsul
dendriplex
np
weigh
pressur
proof
glass
vial
west
pharmaceut
servic
crimpseal
cropharm
inc
meter
valv
epdm
drug
deliveri
system
known
volum
propel
ad
help
manual
syring
pump
hip
homebuilt
high
pressur
filler
order
make
mg
particl
dispers
propel
use
sonic
bath
vwr
set
w
physic
stabil
investig
via
sediment
rate
experi
visual
monitor
qualiti
dispers
function
time
stop
mechan
energi
imag
taken
accord
pmdi
formul
free
dendriplex
np
attempt
describ
si
howev
free
dendriplex
found
dispers
propel
degre
eightstag
andersen
cascad
impactor
aci
copley
scientif
fit
usp
induct
port
oper
flow
rate
l
rel
use
evalu
aerosol
properti
pmdi
formul
prepar
describ
earlier
prior
aci
test
formul
dispers
propel
help
sonic
bath
min
five
actuat
fire
wast
next
actuat
depend
sirna
concentr
formul
fire
aci
interv
test
aci
disassembl
actuat
ac
induct
port
ip
stage
rins
kept
ml
rnase
free
diwat
h
order
break
watersolubl
csla
shell
mannitol
microparticl
contain
dendriplex
sampl
frozen
overnight
lyophil
labconco
freez
zone
mbar
h
collect
powder
dissolv
te
buffer
ph
incub
known
mass
heparin
equival
u
per
sirna
describ
si
min
order
dissoci
sirna
pamam
sampl
frozen
overnight
load
slot
nondenatur
agaros
gel
follow
electrophoresi
condit
appli
gel
retard
assay
sirna
content
aci
stage
quantifi
densitometri
use
imagej
base
electrophoresi
imag
appropri
control
presenc
absenc
sirna
describ
earlier
aerosol
characterist
thu
calcul
fine
particl
fraction
fpf
sirna
content
respir
stage
aci
stage
filter
total
sirna
content
releas
impactor
ip
filter
exclud
sirna
remain
actuat
ii
respir
fraction
rf
sirna
content
collect
stage
filter
total
sirna
releas
impactor
iii
sirna
recov
sirna
content
singl
puff
dose
iv
mass
median
aerodynam
diamet
mmad
v
geometr
standard
deviat
gsd
mmad
gsd
calcul
describ
aci
experi
perform
duplic
n
originpro
use
perform
statist
analysi
data
compar
use
oneway
analysi
varianc
anova
follow
tukey
posthoc
test
mean
consid
statist
signific
differ
p
valu
dendriplex
differ
np
ratio
prepar
character
respect
morpholog
size
surfac
charg
accord
afm
sem
ls
result
summar
tabl
detail
character
one
np
ratio
np
includ
afm
sem
micrograph
shown
figur
observ
hydrodynam
diamet
dendriplex
vari
substanti
np
ratio
measur
ls
size
averag
np
ratio
combin
nm
valu
confirm
sem
size
averag
nm
sinc
techniqu
provid
good
represent
size
dendriplex
solut
prefer
size
estim
afm
imag
nm
discrep
size
dendriplex
obtain
ls
afm
imag
alreadi
like
due
sampl
prepar
seen
size
dendriplex
usual
display
signific
heterogen
case
polyplex
prepar
cation
polym
heterogen
attribut
electrostat
entrop
natur
complex
overal
surfac
charg
dendriplex
fairli
similar
show
specif
trend
function
np
either
averag
valu
mv
also
agreement
previou
studi
dendriplex
pamam
abil
form
complex
sirna
function
np
ratio
investig
gel
electrophoresi
combin
picogreen
assay
result
summar
tabl
figur
complex
effici
ce
sirna
seen
low
np
howev
almost
sirna
complex
pamam
dendrim
np
ratio
sirna
ce
quantit
result
assess
picogreen
uncomplex
sirna
remain
solut
dendriplex
format
ie
indirect
method
quantifi
sirna
confirm
gel
electrophoresi
inset
figur
sirna
band
seen
disappear
gel
np
ratio
increas
indic
sirna
larg
complex
pamam
dendrim
thu
unabl
flow
pore
gel
compar
lane
dendriplex
form
np
lane
untreat
sirna
control
therefor
result
reinforc
observ
highli
posit
charg
pamam
abl
condens
sirna
np
effici
sinc
littl
uncomplex
sirna
found
free
supernat
complex
process
np
sirna
vulner
degrad
one
import
potenti
advantag
use
nanocarri
sirna
therapeut
technolog
abil
protect
frail
cargo
thu
order
evalu
abil
pamam
protect
sirna
rnase
degrad
dendriplex
form
sever
np
ratio
incub
rnase
lowest
concentr
found
digest
free
sirna
complet
rnase
per
sirna
seen
si
h
follow
rnase
inhibitor
heparin
treatment
gel
electrophoresi
releas
quantifi
nondegrad
sirna
result
present
figur
pamam
seen
effici
protect
sirna
rnase
degrad
upon
complex
seen
figur
test
np
ratio
sirna
releas
dendriplex
kept
contact
rnase
lane
compar
sirna
extract
dendriplex
expos
rnase
lane
posit
control
respect
next
dendriplex
form
np
incub
increas
concentr
rnase
per
sirna
h
follow
rnase
inhibitor
heparin
treatment
gel
electrophoresi
order
probe
protect
effici
provid
dendrim
increas
rnase
concentr
result
shown
figur
indic
sirna
suffici
protect
rnase
degrad
upon
complex
pamam
even
rel
low
np
ratio
np
sirna
well
protect
kept
contact
high
concentr
rnase
per
sirna
figur
compar
sirna
dendriplex
incub
presenc
lane
absenc
lane
rnase
sirna
releas
dendriplex
evalu
vitro
citratephosph
buffer
ph
order
mimic
cytosol
endosomeslysosom
result
shown
figur
indic
sirna
vitro
releas
profil
dendriplex
np
highli
depend
upon
ph
releas
much
slower
acid
medium
physiolog
ph
low
ph
primari
tertiari
amin
pamam
consequ
electrostat
interact
posit
charg
dendrim
neg
charg
sirna
increas
result
stronger
bind
lower
sirna
releas
low
ph
physiolog
ph
tertiari
amin
deproton
primari
amin
decreas
electrostat
interact
sirna
result
releas
sirna
increas
higher
ph
degre
compact
observ
lower
ph
also
manifest
fact
burst
releas
observ
ph
hand
physiolog
ph
burst
releas
observ
day
initi
load
sirna
dendriplex
day
observ
sirna
releas
dendriplex
correspond
pmol
result
figur
show
total
sirna
complex
releas
dendriplex
np
respect
day
citratephosph
buffer
ph
literatur
result
avail
vitro
releas
sirna
pamam
dendriplex
contrast
result
obtain
releas
oligonucleotid
pei
np
pb
ph
releas
pei
day
ie
releas
faster
pei
np
np
result
somehow
similar
observ
releas
slightli
faster
np
np
buffer
ph
like
due
oper
ie
dendriplex
form
higher
np
increas
content
contribut
rapid
entri
water
molecul
dendriplex
water
molecul
penetr
throughout
interior
caus
dendrim
structur
swell
due
favor
interact
water
molecul
primari
tertiari
amin
thu
releas
sirna
howev
amount
sirna
releas
dendriplex
np
statist
signific
differ
np
h
day
sinc
vitro
releas
conduct
time
point
demonstr
time
point
sirna
releas
dendriplex
np
statist
significantli
differ
n
time
point
oneway
anova
follow
tukey
posthoc
test
p
valu
cation
dendrit
polym
polypropyleneimin
ppi
polyllysin
pll
pamam
may
induc
signific
vitro
cytotox
due
high
densiti
cation
group
mani
report
discuss
concentr
generationdepend
toxic
critic
factor
consid
evalu
potenti
dendrim
nanocarri
sirna
deliveri
vitro
cytotox
studi
perform
cell
incub
free
pamam
dendriplex
np
accord
mt
cell
prolifer
cell
viabil
result
shown
figur
result
present
figur
indic
viabil
cell
contact
pamam
h
concentr
result
agreement
previou
literatur
report
viabil
cell
low
concentr
evalu
mtt
cell
prolifer
assay
h
sever
work
report
differ
cytotox
result
pamam
thu
cytotox
depend
upon
concentr
cell
type
incub
pamam
dendrim
known
cytotox
caus
membran
ruptur
substanti
relat
format
caviti
cellular
toxic
dendrit
properti
interact
mechan
cellular
uptak
intracellular
fate
like
govern
surfac
toxic
effect
dendriplex
np
highest
np
ratio
appli
gene
knockdown
experi
discuss
next
also
investig
via
mt
assay
h
contact
dendriplex
cell
result
figur
indic
cytotox
dendriplex
np
low
even
highest
concentr
cell
sirna
respect
addit
vitro
viabil
cell
incub
dendriplex
np
h
compar
alon
h
concentr
eg
cell
viabil
figur
b
figur
b
respect
moreov
vitro
viabil
cell
incub
alon
h
found
statist
significantli
differ
np
h
n
oneway
anova
follow
tukey
posthoc
test
p
valu
result
suggest
dendriplex
becom
toxic
alon
report
literatur
cell
macrophagelik
cell
line
show
viabil
h
incub
dendriplex
np
sirna
measur
mtt
sirna
concentr
cell
show
viabil
result
interest
sinc
time
incub
np
ratio
higher
report
work
show
viabil
reduc
cell
incub
mer
dendriplex
np
h
follow
measur
similar
rna
concentr
viabil
cell
thu
seen
vitro
cell
viabil
result
deliveri
sirna
use
pamam
dendrim
variabl
extent
depend
sever
dendrim
surfac
group
gener
physicochem
properti
dendriplex
assay
experiment
condit
cell
type
passag
certainli
interlab
variabl
observ
well
vitro
cytotox
result
necessari
gene
knockdown
studi
work
concentr
region
toxic
gene
knockdown
confound
nonspecif
toxic
harshest
condit
vitro
cytotox
studi
cell
viabil
still
h
incub
dendriplex
np
contain
sirna
respect
contrast
harshest
condit
vitro
gene
knockdown
experi
discuss
next
cell
incub
h
dendriplex
np
contain
nm
sirna
respect
sirna
concentr
viabil
cell
least
figur
expect
higher
smaller
np
ratio
worthwhil
mention
cellular
debri
due
dead
damag
die
cell
gate
fac
analys
prevent
toxic
effect
alon
andor
dendriplex
mask
true
gene
knockdown
fac
cell
stabli
express
egfp
use
investig
gene
silenc
effici
dendriplex
lipofectamin
lf
transfast
tf
commerci
transfect
reagent
select
posit
control
tf
origin
design
transfect
reagent
shown
gene
suppress
use
deliv
sirna
free
sirna
use
neg
control
cell
transduc
egfp
use
refer
cellular
debri
gate
fac
prevent
small
toxic
nanocarri
mask
true
gene
knockdown
transfect
egfp
stabl
cell
perform
dssirna
target
egfp
posit
sequenc
sirna
egfpmismatch
dssirna
nonrelev
neg
sequenc
sirna
result
shown
figur
indic
gene
knockdown
effici
sirna
dendriplex
vari
intermedi
posit
control
lf
tf
free
sirna
gene
silenc
effici
egfp
cell
treat
commerci
reagent
dendriplex
np
found
statist
significantli
differ
egfp
cell
treat
free
sirna
addit
statist
signific
differ
found
compar
egfp
knockdown
effici
function
np
ratio
minimum
n
oneway
anova
follow
tukey
posthoc
test
p
valu
report
literatur
investig
vitro
knockdown
effici
sirna
antisens
oligonucleotid
aon
deliv
via
dendriplex
lung
alveolar
epitheli
cell
dendrosom
dendriplex
form
aon
incorpor
liposom
shown
suppress
gene
express
ca
messeng
rna
mrna
protein
level
dendriplex
form
append
conjug
sirna
provid
luciferas
knockdown
rang
variabl
vitro
gene
silenc
effici
expect
due
differ
target
gene
assay
assess
knockdown
experiment
condit
transfect
eg
np
ratio
treatment
time
sirna
aon
concentr
gener
pamam
dendrim
presenc
moleculesstructur
carrier
gene
knockdown
result
report
dendriplex
cell
contrast
result
literatur
cell
type
dendriplex
np
caus
inhibit
egfp
express
macrophagelik
human
glioblastoma
cell
line
egfp
knockdown
mous
yolk
sac
embryo
thu
egfp
silenc
effici
obtain
dendriplex
alveolar
epitheli
cell
compar
cell
type
fall
within
rang
report
pamambas
dendriplex
without
help
moleculesstructur
despit
lowtomoder
gene
silenc
vitro
propos
dendriplex
potenti
demonstr
gene
silenc
vivo
follow
optim
focu
work
sinc
pamambas
nanocarreir
shown
promis
result
deliv
sirna
vivo
even
gene
silenc
effici
vivo
lower
compar
observ
due
sirna
potenc
ie
small
amount
sirna
properli
deliv
target
site
shown
suffici
effect
vivo
gene
worth
notic
reduct
egfp
express
cell
also
observ
scrambl
sirna
deliv
use
lf
tf
figur
shown
lfsirna
complex
caus
measur
undesir
gene
silenc
differ
cell
unwant
egfp
suppress
like
due
offtarget
due
toxic
also
due
similar
nucleotid
sequenc
sirna
short
motif
mrna
unrel
gene
target
alter
gene
express
vitro
vivo
also
report
sever
type
nanocarri
includ
linear
branch
polypropylenimin
ppi
diaminobutan
dab
offtarget
effect
rnai
quit
common
issu
consider
develop
rnai
may
hard
still
well
order
test
whether
biolog
activ
sirna
preserv
formul
pmdi
hfa
atmospher
gene
knockdown
activ
dendriplex
form
sirna
lyophil
store
satur
pressur
propel
two
month
compar
control
lyophil
store
gene
knockdown
experi
perform
egfp
cell
discuss
dendriplex
np
ratio
result
shown
figur
even
storag
condit
propel
hfa
observ
sirna
still
biolog
activ
silenc
egfp
express
cell
egfp
knockdown
tf
dendriplex
np
respect
similar
valu
obtain
control
sirna
store
freezer
fre
tf
np
respect
gene
silenc
effici
found
statist
signific
egfp
cell
treat
tfsirna
dendriplex
np
storag
hfa
fre
compar
cell
treat
free
sirna
receiv
importantli
gene
knockdown
effici
provid
dendriplex
np
tf
prepar
sirna
receiv
store
hfa
fre
found
statist
significantli
differ
minimum
n
oneway
anova
follow
tukey
posthoc
test
p
valu
collect
result
indic
biolog
activ
sirna
kept
longterm
exposur
propel
hfa
major
obstacl
region
deliveri
dendriplex
lung
use
oi
devic
dendriplex
order
nanomet
size
optimum
aerosol
size
deep
lung
deposit
micromet
rang
particl
aerodynam
diamet
may
exhal
tend
deposit
mouth
throat
end
digest
tract
moreov
alveolar
macrophag
select
particl
less
effici
toward
larger
smaller
nm
case
pmdi
anoth
hurdl
need
overcom
physic
stabil
microparticl
dispers
suspens
low
dielectr
propel
necessari
therefor
develop
particl
engin
strategi
capabl
form
stabl
suspens
dendriplex
form
microparticl
suitabl
deep
lung
deposit
abl
minim
uptak
alveolar
macrophag
demonstr
work
two
strategi
one
consist
encapsul
dendriplex
within
mannitol
microparticl
via
spray
dri
consist
use
csla
cooligom
shell
form
emulsif
diffus
mannitol
chosen
high
aqueou
solubl
gener
recogn
safe
gra
excipi
wide
use
bulk
agent
nonact
carrier
dri
powder
mannitol
particl
alon
also
shown
less
adhesioncohes
propel
hfa
slower
sediment
rate
superior
aerosol
perform
sugar
csla
cooligom
chosen
watersolubl
interfaci
activ
wo
interfac
emuls
droplet
migratesresid
interfac
form
small
water
droplet
larg
ethyl
acet
organ
phase
emulsif
diffus
dendriplex
kept
within
water
emuls
droplet
encapsul
csla
cooligom
resid
wo
interfac
emuls
droplet
thu
organ
phase
expect
contact
sirna
dendriplex
andor
affect
somehow
dendriplex
aggreg
within
csla
microparticl
addit
csla
cooligom
degrad
nonhfa
shell
disintegr
hfa
break
contact
fluid
line
ester
group
la
microparticl
form
csla
shell
shown
enhanc
physic
stabil
propel
import
detail
nonact
ingredi
use
form
microparticl
mannitol
csla
readili
dissolv
aqueou
fluid
line
lung
thu
releas
nanos
dendriplex
consequ
minim
alveolar
macrophag
uptak
addit
also
worthwhil
point
previous
shown
csla
impact
gene
transfer
potenti
cslabas
microparticl
carrier
cspdna
size
morpholog
csla
mannitol
microparticl
contain
dendriplex
np
evalu
ls
sem
result
shown
figur
microparticl
load
dendriplex
np
instead
np
even
though
dendriplex
np
result
similar
vitro
gene
knockdown
effici
shown
figur
np
produc
slightli
smaller
stabl
dendriplex
solut
pleas
refer
tabl
np
hydrodynam
diamet
csla
mannitol
microparticl
measur
ls
found
respect
shown
figur
averag
standard
deviat
calcul
base
eight
n
independ
batch
result
suggest
spheric
dendriplex
carri
microparticl
desir
size
rang
appropri
deep
lung
worthwhil
mention
size
dendriplex
np
measur
ls
contact
microparticl
aqueou
solut
found
nm
nm
csla
mannitol
respect
size
distribut
ls
shown
inset
figur
averag
standard
deviat
calcul
base
five
n
independ
experi
thu
hydrodynam
diamet
dendriplex
np
releas
shell
readili
compar
tabl
load
csla
mannitol
microparticl
nonstatist
significantli
differ
n
oneway
anova
follow
tukey
posthoc
test
p
valu
demonstr
process
form
microparticl
seem
induc
undesir
irrevers
aggreg
dendriplex
sirna
load
effici
sirna
encapsul
microparticl
initi
content
complex
dendrim
csla
mannitol
microparticl
measur
via
densitometri
use
base
imag
obtain
gel
electrophoresi
inset
figur
use
protocol
discuss
experiment
section
sirna
load
effici
within
microparticl
found
csla
ng
sirna
per
mg
csla
particl
ng
sirna
per
mg
mannitol
particl
mannitol
final
sirna
yield
ww
emulsif
diffus
spray
dri
consid
initi
content
csla
mannitol
respect
integr
sirna
particl
prepar
also
observ
use
gel
imag
inset
figur
sirna
band
particl
prepar
found
similar
posit
gel
untreat
sirna
control
compar
lane
intens
band
lane
correspond
sirna
releas
microparticl
weaker
due
fact
less
sirna
ad
gel
see
load
effici
collect
result
demonstr
feasibl
encapsul
sirnabas
dendriplex
csla
mannitol
microparticl
via
emulsif
diffus
spray
dri
process
respect
sirna
success
load
microparticl
show
appropri
size
formul
pmdi
conserv
integr
hydrodynam
diamet
dendriplex
kept
particl
process
shell
dissolut
sediment
rate
experi
microparticl
contain
dendriplex
satur
pressur
propel
perform
order
evalu
physic
stabil
hfa
microparticl
weigh
pressur
proof
glass
vial
crimp
seal
meter
valv
known
volum
propel
ad
make
mg
particl
dispers
aid
sonic
bath
min
stabil
formul
determin
visual
via
sediment
ratefloccul
function
time
stop
mechan
energi
input
sonic
bath
digit
imag
taken
result
present
inset
figur
dispers
csla
mannitol
microparticl
contain
dendriplex
np
propel
show
good
physic
stabil
aggreg
could
observ
wall
canist
bulk
propel
strong
flocculationirrevers
aggreg
observ
inset
figur
aggreg
form
due
sediment
could
easili
redispers
simpl
manual
agit
case
csla
improv
physic
stabil
compar
dendriplex
alon
dispers
propel
hfa
see
si
aris
due
enhanc
solvat
ester
group
la
chain
csla
propel
case
mannitol
reason
enhanc
stabil
less
clear
expect
improv
densiti
match
sinc
spheric
spraydri
mannitol
microparticl
produc
densiti
g
depend
spraydri
condit
densiti
moreov
fact
cohes
forc
mannitol
hfa
rel
lower
compar
sugar
indic
enhanc
solvat
surfac
propel
rel
observ
quantit
comparison
cohes
interact
csla
particl
mannitol
avail
eightstag
aci
use
quantifi
aerosol
properti
hfabas
formul
contain
mannitol
csla
engin
microparticl
dendriplex
np
load
within
core
describ
earlier
free
dendriplex
neg
control
mannitol
csla
shell
dispers
propel
dendriplex
remain
stuck
onto
wall
canist
thu
aci
test
could
even
perform
sirna
content
microparticl
formul
quantifi
incub
aci
stage
rnase
free
diwat
broke
mannitol
csla
shell
thu
releas
dendriplex
aqueou
solut
follow
freez
lyophil
heparin
decomplex
assay
dissoci
sirna
gel
electrophoresi
densitometri
use
gel
imag
describ
earlier
summari
result
shown
tabl
plot
figur
fpf
import
aerosol
characterist
serv
measur
therapeut
benefici
portion
inhal
mass
sirna
would
reach
lower
respiratori
determin
aci
result
fpf
mannitol
csla
microparticl
determin
respect
excel
fall
within
commerci
hfabas
pmdi
smallmolecul
therapeut
averag
even
though
optim
attempt
case
worth
notic
fpf
formul
significantli
differ
n
oneway
anova
follow
tukey
posthoc
test
p
valu
respir
fraction
rf
sirna
content
collect
stage
filter
total
sirna
releas
found
slightli
higher
pmdi
formul
mannitol
microparticl
csla
result
statist
significantli
differ
n
oneway
anova
follow
tukey
posthoc
test
p
valu
mmad
gsd
properti
character
particl
aerosol
spray
mmad
repres
aerodynam
diamet
ad
mass
basi
gsd
measur
spread
particl
size
around
seen
tabl
mmad
gsd
csla
mannitol
microparticl
load
dendriplex
statist
significantli
differ
mmad
gd
averag
respect
n
oneway
anova
follow
tukey
posthoc
test
p
valu
result
indic
microparticl
strategi
mannitol
csla
would
abl
deliv
sirna
deep
lung
mmad
aci
hydrodynam
diamet
ls
csla
microparticl
similar
averag
respect
differ
mannitol
microparticl
averag
respect
differ
aerodynam
hydrodynam
diamet
particl
somehow
expect
aerodynam
diamet
properti
depend
shape
densiti
size
geometr
diamet
spheric
particl
densiti
geometr
aerodynam
diamet
provid
hydrodynam
diamet
expect
slightli
larger
geometr
due
presenc
solvat
layer
around
particl
signific
differ
strategi
came
form
total
sirna
recov
sirna
content
singl
puff
dose
n
oneway
anova
follow
tukey
posthoc
test
p
valu
fraction
recov
mannitol
formul
recov
csla
formul
singl
puff
dose
mannitol
formul
ng
csla
engin
microparticl
ng
result
indic
strategi
encapsul
csla
microparticl
use
emulsif
diffus
techniqu
seem
greater
effici
deliv
sirna
lung
collect
result
shown
indic
pmdi
formul
microparticl
engin
strategi
propos
produc
aerosol
conduc
deep
deposit
sirna
lung
howev
term
total
sirna
recov
amount
sirna
actuat
pmdi
csla
strategi
display
much
greater
effici
work
demonstr
first
time
abil
formul
sirna
pmdi
carri
great
weight
pmdi
least
expens
wide
use
portabl
oral
inhal
devic
avail
market
today
also
tremend
promis
therapeut
sirna
treat
lung
diseas
indic
mani
ongo
clinic
trial
lung
target
show
complex
sirna
posit
charg
pamam
dendrim
success
silenc
product
gene
model
alveolar
epitheli
cell
aerosol
pmdi
formul
nanos
complex
encapsul
either
gra
compon
mannitol
biodegrad
cooligom
csla
high
respir
fraction
fine
particl
fraction
compar
highli
optim
commerci
pmdi
smallmolecul
therapeut
also
show
even
exposur
propel
hfa
use
pmdi
biolog
activ
sirna
gene
silenc
still
maintain
moreov
dendriplex
shown
preserv
characterist
particl
engin
necessari
featur
reproduc
gene
silenc
abil
deliveri
deep
lung
work
highli
complementari
studi
demonstr
possibl
deliv
sirna
lung
use
dri
powder
import
tool
avail
clinician
target
medic
import
lung
disord
along
pmdi
